World-first clinical trial for treating spinal cord injury
A Phase I human clinical trial is set to commence to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury.
A Phase I human clinical trial is set to commence to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury.
A world-first trial to help improve the lives of Australians living with a debilitating spinal cord injury is a step closer with a $6.8 million Medical Research Future Fund grant.
A state-of-the-art livecyte microscope at the Griffith Institute for Drug Discovery is leading the Spinal Injury Project team toward human clinical trials.
Griffith University’s world-first study into cell transplantation to repair injuries to the nervous system has received a major boost thanks to a $5.4 million funding extension from the MAIC.
Griffith University is seeking five people living with spinal cord injury to be part of stage two of an innovative trial which will test intensive rehabilitation for those living with chronic spinal cord paralysis.
Griffith University researchers have demonstrated that a bacteria can travel through the olfactory nerve in the nose and into the brain in mice, where it creates markers that are a tell-tale sign of Alzheimer’s disease.
A new world order Stan Grant has built an illustrious career as a distinguished Australian and international broadcaster, author and...
Join Stan and Kerry as they explore the opportunities and challenges facing our rapidly and unpredictable changing world order, and what the future might hold for all Australians.
This post has been contributed by Professor Elena Marchetti, Professor of Law at Griffith Law School and Law Futures Centre member.
2021 Australia Dayhonourshave been bestowed upona number ofGriffith Universitystaff, associates and alumni.